Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin.
Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin.
复制标题
DOI:
10.3389/fped.2021.669116
复制
发表时间:
2021
影响因子:
2.6
通讯作者:
Torok KS
中科院分区:
文献类型:
--
作者:
Mirizio E;Liu C;Yan Q;Waltermire J;Mandel R;Schollaert KL;Konnikova L;Wang X;Chen W;Torok KS
The purpose of this study was to explore the skin transcriptional profile in pediatric localized scleroderma (LS) to provide a better understanding of the altered immune and fibrotic pathways promoting disease. LS is a progressive disease of the skin and underlying tissue that causes significant functional disability and disfigurement, especially in developing children. RNA sequencing (RNAseq) technology allows for improved understanding of relevant cellular expression through transcriptome analysis of phases during LS disease progression (more active/inflammatory vs. inactive/fibrotic) and also permits the use of RNA extracted from existing paraffin-embedded skin tissue, which is important in pediatrics. A strong correlation was observed between the comparison of genes expressed between fresh (RNAlater) and paraffinized skin in healthy and LS subjects, supporting the use of paraffinized tissue. LS gene signatures compared to healthy controls showed a distinct expression of an inflammatory response gene signature (IRGS) composed of IFNγ-, IFNα-, and TNFα-associated genes. GSEA© enrichment analysis showed that the IRGS, including interferon-inducible chemokines such as CXCL9, CXCL10, CXCL11, and IFNγ itself, was more highly expressed in LS patients with more inflammatory lesions. The use of paraffinized skin for sequencing was proven to be an effective substitute for fresh skin by comparing gene expression profiles. The prevalence of the IFNγ signature in the lesion biopsies of active LS patients indicates that these genes reflect clinical activity parameters and may be the promoters of early, inflammatory disease.
登录
查看更多内容
影响因子:
5.8
作者:
Angel, P;Szabowski, A
通讯作者:
Szabowski, A
影响因子:
7
作者:
Cieslik M;Chugh R;Wu YM;Wu M;Brennan C;Lonigro R;Su F;Wang R;Siddiqui J;Mehra R;Cao X;Lucas D;Chinnaiyan AM;Robinson D
通讯作者:
Robinson D
影响因子:
3.8
作者:
Jovanović B;Sheng Q;Seitz RS;Lawrence KD;Morris SW;Thomas LR;Hout DR;Schweitzer BL;Guo Y;Pietenpol JA;Lehmann BD
通讯作者:
Lehmann BD
DOI:
10.3899/jrheum.081284
发表时间:
2009-12
期刊:
The Journal of rheumatology
影响因子:
--
作者:
Arkachaisri T;Vilaiyuk S;Li S;O'Neil KM;Pope E;Higgins GC;Punaro M;Rabinovich EC;Rosenkranz M;Kietz DA;Rosen P;Spalding SJ;Hennon TR;Torok KS;Cassidy E;Medsger TA Jr;Localized Scleroderma Clinical and Ultrasound Study Group
通讯作者:
Localized Scleroderma Clinical and Ultrasound Study Group
影响因子:
--
作者:
Bulatovic, Maja;Heijstek, Marloes W.;Wulffraatl, Nico M.
通讯作者:
Wulffraatl, Nico M.